Matt Meyerson headshot

Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute
Professor of Genetics and Medicine, Harvard Medical School
Director, Center for Cancer Genomics, Dana-Farber Cancer Institute
Dana Farber Cancer Institute
617-632-4377
Meyerson Lab
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Authors: Authors: Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D'Andrea A, Fröhling S, Döhner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG.
Cancer Cell
View full abstract on Pubmed
EGFR gene mutations: a call for global x global views of cancer.
Authors: Authors: Sellers WR, Meyerson M.
J Natl Cancer Inst
View full abstract on Pubmed
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.
Authors: Authors: Kobayashi S, Boggon TJ, Dayaram T, Jänne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B.
N Engl J Med
View full abstract on Pubmed
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
Authors: Authors: Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.
Authors: Authors: Dobbin KK, Beer DG, Meyerson M, Yeatman TJ, Gerald WL, Jacobson JW, Conley B, Buetow KH, Heiskanen M, Simon RM, Minna JD, Girard L, Misek DE, Taylor JM, Hanash S, Naoki K, Hayes DN, Ladd-Acosta C, Enkemann SA, Viale A, Giordano TJ.
Clin Cancer Res
View full abstract on Pubmed
Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors.
Authors: Authors: Thomas RK, Greulich H, Yuza Y, Lee JC, Tengs T, Feng W, Chen TH, Nickerson E, Simons J, Egholm M, Rothberg JM, Sellers WR, Meyerson ML.
Cold Spring Harb Symp Quant Biol
View full abstract on Pubmed
Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.
Authors: Authors: Cho D, Kocher O, Lee JC, Tenen DG, Meyerson ML, Janne PA, Halmos B.
J Clin Oncol
View full abstract on Pubmed
The parafibromin tumor suppressor protein is part of a human Paf1 complex.
Authors: Authors: Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH, Meyerson M.
Mol Cell Biol
View full abstract on Pubmed
"Lineage addiction" in human cancer: lessons from integrated genomics.
Authors: Authors: Garraway LA, Weir BA, Zhao X, Widlund H, Beroukhim R, Berger A, Rimm D, Rubin MA, Fisher DE, Meyerson ML, Sellers WR.
Cold Spring Harb Symp Quant Biol
View full abstract on Pubmed
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Authors: Authors: Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG.
Cancer Res
View full abstract on Pubmed